Philippe Busson is a seasoned expert in Product and Technology Compliance and Chemical Management, with a specialization in chemical and environmental substance regulations, including REACH, BPR, and their international equivalents. His expertise spans biopharmaceutical manufacturing, biotechnology, and microplastics, alongside a deep commitment to sustainability. Actively involved in Cytiva’s sustainability initiatives, Philippe is passionate about strategies that align with Sustainable Development Goals (SDGs) and Environmental, Social, and Governance (ESG) frameworks. He is always open to collaborations in sustainability and regulatory compliance, advocating that chemicals pose risks only when mismanaged in purchase, use, storage, and disposal.

Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health.